QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in
CNSX:PMC

Pharmerica Competitors

Add
Compare
Today's Range N/A
50-Day Range
$0.08
MA: $0.08
$0.09
52-Week Range N/A
Volume13,000 shs
Average Volume5,703 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Pharmerica (CNSX:PMC) Vs. ASE, GOLD, RLG, RFR, MLY, and ARQ

Should you be buying PMC stock or one of its competitors? Companies in the industry of "gold" are considered alternatives and competitors to Pharmerica, including (ASE) (ASE), (GOLD.V) (GOLD), (RLG) (RLG), 3737 (RFR), American CuMo Mining (MLY), and Argo Gold (ARQ).

Pharmerica (CNSX:PMC) and (ASE) (CNSX:ASE) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and (ASE)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmericaN/AN/AN/A
(ASE)N/AN/AN/A

Earnings & Valuation

This table compares Pharmerica and (ASE)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmericaN/AN/AN/AN/AN/A
(ASE)N/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and (ASE), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pharmerica0000N/A
(ASE)0000N/A

Pharmerica (CNSX:PMC) and (GOLD.V) (CVE:GOLD) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and (GOLD.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmericaN/AN/AN/A
(GOLD.V)N/AN/AN/A

Earnings & Valuation

This table compares Pharmerica and (GOLD.V)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmericaN/AN/AN/AN/AN/A
(GOLD.V)N/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and (GOLD.V), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pharmerica0000N/A
(GOLD.V)0000N/A

(GOLD.V) has a consensus price target of C$7.50, suggesting a potential upside of 733.33%.

Pharmerica (CNSX:PMC) and (RLG) (CNSX:RLG) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and (RLG)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmericaN/AN/AN/A
(RLG)N/AN/AN/A

Earnings & Valuation

This table compares Pharmerica and (RLG)'s gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmericaN/AN/AN/AN/AN/A
(RLG)N/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and (RLG), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pharmerica0000N/A
(RLG)0000N/A

Pharmerica (CNSX:PMC) and 3737 (CNSX:RFR) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and 3737's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmericaN/AN/AN/A
3737N/AN/AN/A

Earnings & Valuation

This table compares Pharmerica and 3737's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmericaN/AN/AN/AN/AN/A
3737N/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and 3737, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pharmerica0000N/A
373700103.00

3737 has a consensus price target of $0.12, suggesting a potential upside of ∞.

Summary

3737 beats Pharmerica on 1 of the 1 factors compared between the two stocks.

Pharmerica (CNSX:PMC) and American CuMo Mining (CVE:MLY) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and American CuMo Mining's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmericaN/AN/AN/A
American CuMo MiningN/AN/AN/A

Earnings & Valuation

This table compares Pharmerica and American CuMo Mining's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmericaN/AN/AN/AN/AN/A
American CuMo MiningN/AN/AN/AC($0.01)-8.13

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and American CuMo Mining, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pharmerica0000N/A
American CuMo Mining0000N/A

Pharmerica (CNSX:PMC) and Argo Gold (CNSX:ARQ) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and Argo Gold, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pharmerica0000N/A
Argo Gold0000N/A

Profitability

This table compares Pharmerica and Argo Gold's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmericaN/AN/AN/A
Argo GoldN/AN/AN/A

Earnings & Valuation

This table compares Pharmerica and Argo Gold's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmericaN/AN/AN/AN/AN/A
Argo GoldN/AN/AN/AN/AN/A


Pharmerica Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ASE
(ASE)
0.6N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
GOLD
(GOLD.V)
0.9$0.90flatC$0.00N/A0.00Gap Down
RLG
(RLG)
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Up
RFR
3737
1.7N/AN/A$0.00N/A0.00High Trading Volume
MLY
American CuMo Mining
0.8$0.07flatC$0.00N/A-8.13
ARQ
Argo Gold
0.5N/AN/AC$0.00N/A0.00High Trading Volume
CMV
China Minerals Mining
0.6$0.20flatC$0.00N/A0.00High Trading Volume
C
Contact Gold
0.1$0.11flatC$0.00N/A-0.87
Dalradian Resources logo
DNA
Dalradian Resources
0.5N/AN/AC$0.00N/A-56.15
GLDX
Gold X Mining
1.4$2.76flatC$0.00N/A0.00News Coverage
MTO
Metanor Resources Inc. (MTO.V)
0.5$0.58flatC$0.00C$26.37 million-2.17High Trading Volume
MQR
Monarques Gold Co. (MQR.V)
1.3$0.23flatC$0.00C$30.13 million-9.58Gap Up
MAU
Montage Gold
1.8$0.73flatC$0.00N/A-6.35
NM
Northern Empire Resources Corp. (NM.V)
0.5$1.25flatC$0.00N/A-4.77
OLA
Orla Mining
1.1$1.40flatC$0.00N/A-22.95Gap Down
OSI
Osino Resources Corp. (OSI.V)
0.7$1.18flatC$0.00N/A-11.13Analyst Revision
News Coverage
Rio2 logo
ATM
Rio2
0.4$0.68flatC$0.00N/A0.00
ROVR
Rover Metals
0.0$0.08flatC$0.00N/A-5.77Gap Up
RPM
Rye Patch Gold
0.5$1.06flatC$0.00N/A0.00Gap Down
SGX
Sage Gold
0.5$0.02flatC$0.00N/A-0.07Gap Down
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.